LDLR and familial hyperaldosteronism: The clinical impact of an APOE7 mutant appears to be smaller than that of other FH mutations in LDLR, or PCSK9. However, a proportion of individuals with a mutant of APOE7 can be considered to have typical FH who are showing dominant inheritance pattern.